explore -WSS

explore

author：Wikipedia 2025-09-06 04:38:42 - browse：68168

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Dana Farber says 6 studies to be retracted and 31 corrected

WSS

There's an unseen cost to disruptive road

Future doctors need a strong humanities education

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

NYC plans to house migrants on an island in the East River

TikTok, Instagram influencers need more rules for drug ads

leisure time

explore

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Pumping milk in bathrooms at health conferences is common

Virginia high school admissions case could be legal follow

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Jerome Adams on the need for new antivirals for Covid

Dog Aging Project founders on what lies ahead after losing funding

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Why workplace violence is so common in health care

hotspot

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Cardiologists urge adding sexual orientation, gender identity to health records

Illinois to ban advertising for guns allegedly marketed to kids and militants

Democratic lawmaker calls for 'well

What causes osteoarthritis? Researchers study link to brain protein

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

explore

hotspot

focus

hotspot